Transcriptomic evidence for tumor‐specific beneficial or adverse effects of TGFβ pathway inhibition on the prognosis of patients with liver cancer

Therapeutic targeting of the transforming growth factor beta (TGFβ) pathway in cancer represents a clinical challenge since TGFβ exhibits either tumor suppressive or tumor promoting properties, depending on the tumor stage. Thus, treatment with galunisertib, a small molecule inhibitor of TGFβ recept...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Matthis Desoteux, Betty Maillot, Kevin Bévant, Tanguy Ferlier, Raffaële Leroux, Gaëlle Angenard, Corentin Louis, Laurent Sulpice, Karim Boudjema, Cédric Coulouarn
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2023-07-01
Saila:	FEBS Open Bio
Gaiak:	galunisertib gene signature hepatocellular carcinoma survival TGFβ
Sarrera elektronikoa:	https://doi.org/10.1002/2211-5463.13647
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!